Allergan, Inc.

Source Global, Pbc

Eliza Corporation

Allergen, Inc.

Zero Mass Water, Inc.

Michael R Robinson

Patrick Michael Hughes

Alazar N Ghebremeskel

Scott M Whitcup

James A Burke

Lon T Spada

Wendy M Blanda

Cody A Friesen

James Nienyuan Chang

Grant Harrison Friesen

Robert T Lyons

Oleg Boulanov

Kamil Salloum

Alexandra Drane

Lucas Merrow

Rhett M Schiffman

Heath Lorzel

Robert M Burk

David Frederick Woodward

Thomas C Malone

Danny Thang Dinh

Julie Wurster

Ahmet Tezel

Jinping Wan

John T Trogden

John P Kroeker

Jonathan Edward Goldberg

Sougato Boral

Ke Wu

Gyorgy F Ambrus

Terrence J Hunt

Anuradha V Gore

Shimiao Wang

Mohammed I Dibas

Joan-En Chang-Lin

Jeffrey L Edelman

Michael Strehl

Rahul Bhagat

Maximilian Vogl

Hui Liu

Jie Shen

Nasreen R Quibria

Chandrasekar Durairaj

Jaya Giyanani

Roger Kei Aoki

Kimberly McGuinness

Devin F Welty

Werhner C Orilla

Aileen Morgan

Jihao Zhou

Luis Mejiaortega

Justin Zachary Bessant

Haixia Liu

John Krocker

Sungwook Lee

Guadalupe Ruiz

Zoran Novakovic

Vaclav Vojan

Shawn R Davis

Jessica Kreher

David Mucientes

Ina Michaelis

Joan-En Lin

Cindy W Wu

C Eugene Hull

Kun Xu

Julie A Wurster

Marianne M Do

Mohammed Dibas

Iii Clarence E Hull

A James Burke

Clarence E Iii Hull

Ruwen Shi

Orilla Werhner

This disclosure relates to techniques for producing liquid water from ambient air. In certain embodiments, a system includes a regeneration fluid pathway configured to receive a regeneration fluid and a thermal unit configured to heat the regeneration fluid. The system can further include a continuous desiccant unit that comprises an adsorption zone and a desorption zone, as well as a batch desiccant unit that includes a regeneration inlet and a batch desiccant housing. The batch desiccant housing can include a batch desiccant inlet configured to input the ambient air, a batch desiccant outlet configured to output a batch output fluid, and a batch desiccant material. A condenser unit can be configured to produce liquid water from the regeneration fluid, and the system can maximize a water production rate of the condenser unit based on an amount of heat carried by the regeneration fluid.

Systems and methods to produce liquid water extracted from air

Systems for generation of liquid water are provided. In embodiments, the systems comprise a thermal desiccant unit comprising a porous hygroscopic material located within a housing including a fluid inlet and a fluid outlet, a working fluid that accumulates heat and water vapor upon flowing from fluid inlet of the housing, through the porous hygroscopic material, and to the fluid outlet of the housing, a condenser comprising a fluid inlet and a fluid outlet for condensing water vapor from the working fluid; an enthalpy exchange unit operatively coupled between the thermal desiccant unit and the condenser, wherein the enthalpy exchange unit transfers enthalpy between the working fluid output from the thermal desiccant unit and the working fluid input to the thermal desiccant unit, and, wherein the enthalpy exchange unit transfers enthalpy between the working fluid output from the condenser and the working fluid input to the condenser.

Thermal desiccant systems and methods for generating liquid water

A water generation system for generating liquid water from a process gas containing water vapor is disclosed. In various embodiments, the water generation systems comprise a solar thermal unit, a condenser and a controller configured to operate the water generation system between a loading operational mode and a release operational mode for the production of liquid water. A method of generating water from a process gas is disclosed herein. In various embodiments, the method comprises flowing a process gas into a solar thermal unit, transitioning from the loading operational mode to a release operational mode; flowing a regeneration fluid into the solar thermal unit and the condenser during the release operational mode; and, condensing water vapor from the regeneration fluid to produce liquid water.

Systems and methods for generating water from air

Described herein are methods and compositions for the treatment of ocular conditions and for the improvement of vision parameters using pharmaceutically acceptable ophthalmic pilocarpine formulations. A nonlimiting example of an ocular condition that may be treated with the methods and compositions disclosed herein is presbyopia.

Presbyopia treatments

Solar thermal units and methods of operating solar thermal units for the conversion of solar insolation to thermal energy are provided. In some examples, solar thermal units have an inlet, and a split flow of heat absorbing fluid to either side of the solar thermal unit, along a first fluid flow path and a second fluid flow path. Optionally, one or more photovoltaic panels can be provided as part of the solar thermal unit, which may convert solar insolation to electric power that may be used by a system connected to the solar thermal unit.

Solar thermal unit

Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants can be placed in an eye to treat one or more ocular conditions, such as an ocular vasculopathy or glaucoma, including reduction of an elevated intraocular pressure.

Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof

Improved dermal filler formulation comprising a hyaluronic acid and a botulinum toxin.

Dermal filler

Apparatus and methods for introducing a solid or semi-solid intraocular drug-containing implant into the anterior chamber of an eye are described. The drug-containing implant can be a rod-shaped biodegradable implant that may provide for the extended release of the drug and may be effective for treating a medical condition of the eye. The apparatus is ergonomically designed in the shape or style of a pen with tactile surfaces for easy gripping, a needle-rotation knob to permit orientation of the needle bevel in relation to the eye, and a spring-actuated mechanism for consistent deployment of the implant.

Intraocular implant delivery apparatus and methods of use thereof

Prostamide-containing biodegradable intraocular implants, prostamide compounds, prostamide-containing pharmaceutical compositions, and methods for making and using such implants and compositions for the immediate and sustained reduction of intraocular pressure and treatment of glaucoma in an eye of a patient are described.

Prostamide-containing intraocular implant

Biodegradable drug delivery systems, such as extruded implants, for the sustained delivery of a protein to an ocular region of the eye or intraarticular region in the body are described. The drug delivery systems may be used to treat a variety of ocular and medical conditions, including macular degeneration. Methods for using and making the drug delivery systems are also described. The drug delivery systems can be in the form of extruded filaments configured for placement in an ocular region such as the vitreous body or anterior chamber of the eye.

Biodegradable drug delivery systems for the sustained release of proteins

Biocompatible, bioerodible implants and microspheres include latanoprost and a biodegradable polymer effective, when placed intraocular (such as into the subtenon space) to treat glaucoma.

Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof

Growing community of inventors

Irvine, CA, United States of America

Michael R Robinson